![]() ![]() The 5yr yield always leads the 10yr cycle and just test 1.35 (the equivalent of 10yr 1.45) in a traditional lead cycle.Ī 5yr yield move below 1.3028 would represent a break that would lead the 10yr. It is the bear pressure in late 20 that exhibits a stronger cycle to break these key lows of 1.351.40 on the 10yr. In this chart we outline compelling pressure points that show risk of brief break of the 1.40 macro triple low ahead of a recovery into the summer toward 2. Of course, what is most important to us is that the price of the stock is confirming the fundamental story.īuy this breakout, and secondarily buy any pullback toward 97 HK base support (if applicable). The fundamental story is easy to see, as the company has delivered top line annual sales growth of over 60 for the past four years coupled with an EPS CAGR of 129 over the past three years (FactSet). We believe WuXi Biologics offers a timely opportunity to take advantage of what we expect are higher prices ahead for this biotechnology growth stock. HK) Health Care remains one of our favorite Sector overweights, both globally (ex-US) and in Greater China. Weekly trendline support comes in just under 22,000 with time translation, acting as a macro inflection marker.ĭaily cycle triple tops stand out as does the recent rejection at 24,000 marking a point below broken trendline.Ĭompany Spotlight: Buy WuXi Biologics Inc. ![]() Staying below 23,600 puts addition pressure to reach for support near 22,000. This places macro bear pressure the recent rejection of the daily cycle at 24,000. ![]() Nikkei Triple Top Threat Nikkei 225 (NKY INDEX) shows a 24,000 triple top threat on the weekly cash chart going back to the high in late 2017, 2018 and the recent topping pattern. Index Of Triple Threat Download Investor Solutions. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |